MANERBA, MARCELLA
Dettaglio
MANERBA, MARCELLA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Assegnisti
Pubblicazioni
Risultati 1 - 20 di 25 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells | Manerba M, Di Ianni L, Govoni M, Comparone A, Di Stefano G. | 2018 | PLOS ONE | 1.01 Articolo in rivista | ||
2 | Albumin-drug conjugates in the treatment of hepatic disorders. | Fiume L;Manerba M;Di Stefano G | 2014 | EXPERT OPINION ON DRUG DELIVERY | 1.01 Articolo in rivista | - | |
3 | Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. | Ianni M; Manerba M; Di Stefano G; Porcellini E; Chiappelli M; Carbone I; Licastro F. | 2010 | IMMUNITY & AGEING | 1.01 Articolo in rivista | ||
4 | Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. | Boga C.; Fiume L.; Baglioni M.; Bertucci C.; Farina C.; Kratz F.; Manerba M.; Naldi M.; Di Stefan...o G. | 2009 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
5 | Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons. | Spisni E; Valerii MC; Manerba M; Strillacci A; Polazzi E; Mattia T; Griffoni C; Tomasi V. | 2009 | NEUROTOXICOLOGY | 1.01 Articolo in rivista | - | |
6 | Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. | Fiume L.; Manerba M.; Vettraino M.; Di Stefano G. | 2011 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1.01 Articolo in rivista | - | |
7 | Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. | Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Rober...ti M.; Recanatini M. | 2012 | CHEMMEDCHEM | 1.01 Articolo in rivista | - | |
8 | Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 | Vettraino M; Manerba M; Govoni M; Di Stefano G. | 2013 | ANTI-CANCER DRUGS | 1.01 Articolo in rivista | - | |
9 | Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. | Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G. | 2012 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
10 | Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors | Sebastiano Rupiani; Rosa Buonfiglio; Marcella Manerba; Lorenza Di Ianni; Marina Vettraino; Elisa ...Giacomini; Matteo Masetti; Federico Falchi; Giuseppina Di Stefano; Marinella Roberti; Maurizio Recanatini | 2015 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | - | |
11 | Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. | Fiume L; Manerba M; Vettraino M; Di Stefano G | 2010 | PHARMACOLOGY | 1.01 Articolo in rivista | - | |
12 | Inhibition of lactate dehydrogenase activity as an approach to cancer therapy | Luigi FIUME; Marcella MANERBA; Marina VETTRAINO; Giuseppina DI STEFANO | 2014 | FUTURE MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | - | |
13 | Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. | Fiume L.; Vettraino M.; Manerba M.; Di Stefano G. | 2011 | PHARMACOLOGICAL RESEARCH | 1.01 Articolo in rivista | - | |
14 | Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment | Balboni A.; Govoni M.; Rossi V.; Roberti M.; Cavalli A.; Di Stefano G.; Manerba M. | 2021 | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 1.01 Articolo in rivista | - | |
15 | Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment | Di Stefano, Giuseppina; Manerba, Marcella; Di Ianni, Lorenza; Fiume, Luigi | 2016 | FUTURE MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | - | |
16 | Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells | Manerba, Marcella; Di Ianni, Lorenza; Govoni, Marzia; Roberti, Marinella; Recanatini, Maurizio; D...i Stefano, Giuseppina | 2017 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
17 | Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. | M. Manerba; L. Di Ianni; L. Fiume; M. Roberti; M. Recanatini; G. Di Stefano | 2015 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
18 | LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells | Manerba, Marcella; Di Ianni, Lorenza; Govoni, Marzia; Roberti, Marinella; Recanatini, Maurizio; D...i Stefano, Giuseppina | 2017 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
19 | Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir | Manerba, Marcella; Govoni, Marzia; Manet, Ilse; Leale, Antoniofrancesco; Comparone, Antonietta; D...i Stefano, Giuseppina | 2019 | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 1.01 Articolo in rivista | - | |
20 | NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases | Di Stefano G; Manerba M; Vettraino M | 2013 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | - |